Details for New Drug Application (NDA): 071617
✉ Email this page to a colleague
The generic ingredient in HALOPERIDOL is haloperidol decanoate. There are twenty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the haloperidol decanoate profile page.
Summary for 071617
Tradename: | HALOPERIDOL |
Applicant: | Teva Pharms |
Ingredient: | haloperidol lactate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CONCENTRATE;ORAL | Strength | EQ 2MG BASE/ML | ||||
Approval Date: | Dec 1, 1988 | TE: | RLD: | No |
Complete Access Available with Subscription